Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question πŸ’­
Fanwood Borough

Stage IIB, I have two sites in my left breast. One is Ductal Carcinoma in Situ, and is ER+ and PR+. The other site is within some calcifications, and is Invasive Ductal Carcinoma (IDC) and is ER- and PR- an HER2+. I had DCIS in 2008 in the right breast, had radiation and lumpectomy. I have my first meeting with the Oncologist on Tues. 8/25/26. I am wondering what type of chemo she will want to start and what the side effects will be. Will I lose my hair? Mouth sores? Nausea?

August 22
 · 
Be the first to react
A MyBCTeam Member

Hi AMcN! Welcome, from another HER2+ gal (IDC Stage 2, Grade 3)- just wanted to let you know that although the protocols for us is long (it took me a little over a year to complete chemo and targeted therapy) the drugs are very effective. I am now 6 years out of treatment and so far, so good.

Reach out anytime about anything, we look forward to getting to know you! Keeping you in prayers for a good meeting with the oncologist on the 25th! Hugs!

August 22
MyBCTeam

What chemotherapy is typically recommended for Stage IIB breast cancer with HER2+ and hormone receptor-positive sites?

First, it's completely understandable to want to walk into Tuesday's appointment feeling prepared β€” knowledge is power! Because your situation involves two distinct tumor types, your oncologist will Show Full Answer

What chemotherapy is typically recommended for Stage IIB breast cancer with HER2+ and hormone receptor-positive sites?

First, it's completely understandable to want to walk into Tuesday's appointment feeling prepared β€” knowledge is power! Because your situation involves two distinct tumor types, your oncologist will carefully tailor a treatment plan. Here's what is commonly used for your profile:

Given your HER2+ IDC, a regimen called TCHP is commonly recommended. It includes:

- T β€” Docetaxel (chemotherapy)
- C β€” Carboplatin (chemotherapy)
- H β€” Trastuzumab/Herceptin (HER2-targeted therapy)
- P β€” Pertuzumab/Perjeta (HER2-targeted therapy)

Because your DCIS site is ER+ and PR+, hormone therapy (like tamoxifen) will likely also be part of your plan after surgery. Will you lose your hair?

Hair loss is one of the most common side effects of chemotherapy, affecting between 40% and 100% of people on chemo regimens. It typically begins within 2–4 weeks of starting treatment and can affect:

- Scalp
- Eyebrows
- Eyelashes
- Underarms and pubic area

The good news is that hair usually grows back after treatment ends, though it can take several months. Ask your oncologist about scalp cooling caps, which can help reduce hair loss during treatment. What about mouth sores and nausea?

Both are possible side effects. Carboplatin and docetaxel (both in TCHP) can cause mouth sores. To manage them:

- Keep your mouth clean and moist
- Tell your care team early if sores develop β€” they may adjust your dose if severe
- Make your dentist part of your care team before starting treatment

Nausea is also common with chemotherapy. Your oncologist will likely prescribe anti-nausea medications to help manage this.

You're going into Tuesday's appointment with great awareness β€” write all these questions down to bring with you!

August 22

Related Questions

View All
A MyBCTeam Member asked a question πŸ’­
Pittsburgh, PA

A MyBCTeam Member asked a question πŸ’­
Crivitz, WI